Physician perspectives on de-intensifying diabetes medications

Natalia Genere, Robert M. Sargis, Christopher M. Masi, Aviva G. Nathan, Michael T. Quinn, Elbert S. Huang, Neda Laiteerapong

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Guidelines for diabetes care recommend that physicians select individualized glycemic goals based on life expectancy, diabetes duration, comorbidity, and resources/support. When patients have stable hemoglobin A1C (HbA1C) levels, guidelines lack recommendations on when diabetes medications should be de-intensified. To understand physicians' perspectives on de-intensifying diabetes medications in patients with type 2 diabetes. Cross-sectional survey, (February-June, 2015). Academic medical center and suburban integrated health system. Primary care and endocrinology physicians. Physicians' self-reported: awareness, agreement, and frequency of individualizing HbA1C goals; practice of de-intensifying diabetes medications; HbA1C values at which physicians de-intensify diabetes medications; and other patient factors physicians consider when de-intensifying diabetes medications. Response rate was 73% (156/213). Most physicians (78%) responded they were familiar with recommendations to individualize HbA1C goals. For patients with stable HbA1C levels, 80% of physicians reported they had initiated conversations about stopping medications; however, physicians differed in predefined HbA1C levels used to initiate conversations (HbA1C < 5.7%: 14%; HbA1C < 6.0%: 31%; HbA1C<6.5%: 22%; individualized level: 21%). In multiple logistic regression, women physicians (odds ratio [OR] 3.0; confidence interval [CI] 1.1-8.2; P=0.03) and physicians practicing fewer than 20 years (OR 2.8; CI 1.01-7.7; P=0.048) were more likely to report de-intensifying diabetes medications. Individualizing glycemic goals and de-intensifying treatments are concepts well accepted by physicians in our sample. However, physicians vary considerably in reporting how they carry out recommendations to individualize and may be missing opportunities to stop or taper diabetes medications based on patients' individualized glycemic goals.

Original languageEnglish
Article numbere5388
JournalMedicine (United States)
Issue number46
StatePublished - 2016


  • Diabetes
  • Endocrinology
  • Outcomes research
  • Patient centered care
  • Patient preference
  • Patient satisfaction
  • Quality of care


Dive into the research topics of 'Physician perspectives on de-intensifying diabetes medications'. Together they form a unique fingerprint.

Cite this